Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.57 -0.02 (-0.78%)
As of: Oct 2, 2026 · 12:39 PM EDT

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2020)

Updated

Rocket Pharmaceuticals' Other Operating Expenses came in at -$29,000 for Q2 2025.

Analysis

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2020) Analysis & Trends

Going back to Q4 2017, Rocket Pharmaceuticals' Other Operating Expenses data covers 7 quarters.

  • The Q2 2025 figure represents the highest quarterly Other Operating Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rocket Pharmaceuticals 288.09 Mn 288.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,000.00
Dec 31, 2018 1,000.00
Sep 30, 2018 -39,000.00
Jun 30, 2018 -5,000.00
Mar 31, 2018 15,000.00
Dec 31, 2017 1,000.00
API Access

Rocket Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RCKT&period=max&api_key=YOUR_API_KEY